North America Medical Device Reprocessing Market

North America Single-Use Medical Device Reprocessing Market Analysis

The North America Single-Use Medical Device Reprocessing Market is expected to register a CAGR of 5.5% during the forecast period.

A single hospital can divert over a ton of devices from the waste stream each year. According to the Association of Medical Device Reprocessors (AMDR), as of 2017, more than 3,000 US hospitals were purchasing reprocessed SUDs, and saving more than USD 600,000 annually, through their recycling and redistribution initiatives.

Along with cost reduction, it also results in environmental sustainability. SUD reprocessing is one of the top healthcare supply chain strategies used to reduce costs and optimize resources. The aforementioned factors are anticipated to contribute towards the development of industry in the immediate future. However, the lack of dedicated SUD reprocessing facilities in emerging markets is currently a huge opportunity for this market, while the unauthorized overuse of reprocessed SUDs in emerging markets is currently the major challenge faced by this market.

North America Single-Use Medical Device Reprocessing Market Trends

Sequential Compression Sleeves by Class II Device Segment is Poised to Register Robust Growth

• Sequential compression sleeves are designed to increase venous blood flow in patients with deep vein thrombosis and pulmonary embolism. Compression sleeves are considered reusable, as they can withstand the necessary cleaning and sterilization process.
• The quality of the device and physical characteristics are not likely to be affected by reprocessing and the device remains safe and effective for its intended use. Hospitals are believed to save USD 300,000 by reprocessing compression sleeves. FDA reported that in 25% of all hospitals in the United States that use SUDs, sequential compression devices constitute about 15.8% of the reprocessed items. Compression sleeves account for the greatest volume of the overall business of SUDs reprocessing.
• Stryker is the leading provider of reprocessed compression sleeve devices and has FDA clearance for the product offering. The company's reprocessed compression devices are intended for use in preventing deep vein thrombosis, reducing post-operative pain and swelling, enhancing blood circulation, and reducing wound healing time.
• The annual savings estimate of Stryker for DVT compressor sleeves is USD 27,950. Currie Medical Specialties Inc. and Covidien (Medtronic) have also received 510K FDA clearances to reprocess compression sleeves.
• Reprocessed Kendall SCD express compression sleeves and reprocessed Kendall SCD comfort compression sleeves from Covidien (Medtronic) received FDA clearance on January 19, 2017. Medline also offers reprocessed compression sleeves.

North America Single-Use Medical Device Reprocessing Industry Overview

The North America Single-use Medical Device Reprocessing Market is moderately competitive and consists of several major players. In terms of market share, a few of the major players currently dominate the market. The major market players include Hygia, Medline ReNewal, NEScientific, ReNu Medical, SterilMed among others. In a bid to achieve greater market penetration, the major players are resorting to various strategies such as mergers and acquisitions. For instance, in April 2020, Yale New Haven Health formed a strategic partnership with Medline.

North America Single-Use Medical Device Reprocessing Market Leaders